To maximize expected reward,
an important target estimand is
E.g., if we are performing a trial for an anticoagulant, we might consider our outcome to contain the variables stroke and bleed, and then
is the joint probability of having a stroke and bleed post treatment, given patient covariates.
Instead, often, the treatment effect of an anticoagulant is estimated. This then requires that one designate a primary outcome such as stroke. Often, it seems, this can detract from estimation of the secondary outcomes, if the trial is not powered for the secondary outcome, for example.
Leave a comment